RISS STAGE II PLASMA CELL MYELOMA
Clinical trials for RISS STAGE II PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RISS STAGE II PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for RISS STAGE II PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New quadruple therapy aims to outsmart myeloma in major trial
Disease control Recruiting nowThis study tests whether adding a fourth drug (bortezomib) to a standard three-drug combination (daratumumab, lenalidomide, and dexamethasone) works better for people newly diagnosed with multiple myeloma who are not eligible for early stem cell transplant. About 1,450 participan…
Matched conditions: RISS STAGE II PLASMA CELL MYELOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
2000 volunteers help scientists create a master reference for cancer blood tests
Knowledge-focused Recruiting nowThis study collects blood and tissue samples from 2000 people—some with cancer, some without—to create a blinded reference set. Researchers will use these samples to evaluate how well new blood tests can detect many types of cancer early. The goal is to improve the accuracy of mu…
Matched conditions: RISS STAGE II PLASMA CELL MYELOMA
Sponsor: Alliance for Clinical Trials in Oncology • Aim: Knowledge-focused
Last updated May 26, 2026 06:21 UTC